TELLAPRIALBI
Published by: Howto Health
Description
The APRI and ALBI scores are commonly used in clinical routine to assess the severity of illness for patients suffering from hepatical tumors and to predict postoperative liver dysfunction after resection. Combining these scores, the APRI+ALBI score provides even better performance of assessment and prediction regarding 30-day-mortality after surgery.
TELLAPRIALBI allows you to
- enter relevant lab parameters (platelet count, AST, albumin and bilirubin levels)
- automatically compute APRI, ALBI and APRI+ALBI scores for comparative review
- select from a variety of tumor types together with the respective extent of resection and
- view clinical interpretation plots regarding 30-day-mortality post operation highlighting the risk class indicated by the APRI+ALBI score.
The app is intended for educational use by medical professionals and to allow review of the APRI+ALBI score and its predictive quality. All information entered into the app and computed by it is processed exclusively within the app on the users device and no information is stored, transmitted or shared by the app.
TELLAPRIALBI was developed jointly by the Translational Experimental Liver Laboratory at the Medical University of Vienna (TELLVIENNA) and Howto Health GmbH. It is based on a joint research paper which is currently in print at BMJ Open. The app is published by and the service is provided by Howto Health GmbH.
Hide..
Show more..
TELLAPRIALBI allows you to
- enter relevant lab parameters (platelet count, AST, albumin and bilirubin levels)
- automatically compute APRI, ALBI and APRI+ALBI scores for comparative review
- select from a variety of tumor types together with the respective extent of resection and
- view clinical interpretation plots regarding 30-day-mortality post operation highlighting the risk class indicated by the APRI+ALBI score.
The app is intended for educational use by medical professionals and to allow review of the APRI+ALBI score and its predictive quality. All information entered into the app and computed by it is processed exclusively within the app on the users device and no information is stored, transmitted or shared by the app.
TELLAPRIALBI was developed jointly by the Translational Experimental Liver Laboratory at the Medical University of Vienna (TELLVIENNA) and Howto Health GmbH. It is based on a joint research paper which is currently in print at BMJ Open. The app is published by and the service is provided by Howto Health GmbH.
Screenshots
User Rating
App is not rated in Chile yet.
Ratings History
TELLAPRIALBI Installs
Last 30 days
TELLAPRIALBI Revenue
Last 30 daysTELLAPRIALBI Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
Keywords
TELLAPRIALBI Competitors
| Name | Reviews | Recent release | |
|---|---|---|---|
Pancreatic Cancer Action
Manage your condition better
|
0
|
1 year ago | |
MELD Score Calculadora
Trasplante de Hígado
|
0
|
3 years ago | |
mEMA-10: Legacy
N/A
|
0
|
1 year ago | |
HIV Clinical Job Aids
|
0
|
9 months ago | |
FRS Risk
fistula calculation
|
0
|
2 years ago | |
Inside Vascular Interventions
|
0
|
1 year ago | |
Pancreatic Surgery
|
0
|
1 year ago | |
Sleep Apnea Screener 2
Sleep Apnea screens on mobile.
|
0
|
1 year ago | |
EVIglance
Evidence at a glance
|
0
|
4 months ago | |
Liver+AI
|
0
|
10 months ago |
TELLAPRIALBI Revenue and Downloads
Gain valuable insights into TELLAPRIALBI performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
-
Howto Health
- Languages
- English
- Recent version
- 1.3.2 (2 years ago )
- Released on
- Jan 7, 2021 (3 years ago )
- Also available in
- Germany, Poland, South Korea, Kuwait, Kazakhstan, Lebanon, Mexico, Malaysia, Netherlands, Norway, New Zealand, Peru, Pakistan, Japan, Portugal, Saudi Arabia, Sweden, Singapore, Thailand, Turkey, Taiwan, United States, Vietnam, South Africa, Ecuador, Australia, Brazil, Belarus, Canada, Switzerland, Chile, China, Colombia, Dominican Republic, Algeria, Argentina, Egypt, Spain, France, United Kingdom, Greece, Hong Kong, Hungary, Israel, India, Italy
- Last updated
- 3 weeks ago